Koers Chromadex Corp OTC Bulletin Board
Aandelen
CDXC
US1710771007
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 96,57 mln. 89,36 mln. | Omzet 2025 * | 114 mln. 105 mln. | Marktkapitalisatie | 229 mln. 212 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -1 mln. -925K | Nettowinst (verlies) 2025 * | 4 mln. 3,7 mln. | EV/omzet 2024 * | 2,38 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,01 x |
K/w-verhouding 2024 * |
-379
x | K/w-verhouding 2025 * |
48,5
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 64,21% |
Recentste transcriptie over Chromadex Corp
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Fried
CEO | Chief Executive Officer | 64 | 09-07-15 |
Frank Jaksch
FOU | Founder | 55 | 01-01-99 |
Brianna Gerber
DFI | Director of Finance/CFO | 44 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 27-03-17 |
Hamed Shahbazi
BRD | Director/Board Member | 49 | 09-08-22 |
Frank Jaksch
FOU | Founder | 55 | 01-01-99 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+48,54% | 56,87 mld. | |
+37,15% | 39,72 mld. | |
-6,02% | 39,27 mld. | |
-6,90% | 28,73 mld. | |
+12,97% | 26,21 mld. | |
-16,91% | 19,79 mld. | |
+31,71% | 12,28 mld. | |
+28,18% | 12,23 mld. | |
+0,38% | 12,12 mld. |
- Beurs
- Aandelen
- Koers CDXC
- Koers CDXC